CM Life Sciences, Inc. (CMLF)
|Net Income (ttm)||n/a|
|Trading Day||March 5|
|Day's Range||13.67 - 16.58|
|52-Week Range||9.66 - 27.18|
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM Life Sciences, Inc. - CMLF
NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities...
NEW YORK, Feb. 11, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CM Life Sciences, Inc. ("CMLF...
Keith Meister, Eli Casdin on new SPAC and data-driven health care
CNBC's "Halftime Report" team discusses the CM Life Sciences SPAC and the future of data-driven health care with Keith Meister of Corvex Capital and Eli Casdin of Casdin Capital.
Sema4's Eric Schadt on health intelligence and going public via SPAC
CNBC's "Halftime Report" team discusses SPACs and the future of AI and data in the health care sector with Sema4 founder and CEO Eric Schadt. Sema4 is a patient-centered health intelligence co...
CM Life Sciences (CMLF) stock is soaring higher on Wednesday after announcing plans to take Sema4 public via a SPAC merger. The post CMLF Stock: 13 Things to Know About CM Life Sciences and th...
Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth
NEW YORK & STAMFORD, Conn.--(BUSINESS WIRE)--Sema4, an AI- and machine learning-driven patient-centered genomic and clinical data intelligence company, and CM Life Sciences (Nasdaq: CMLF), a s...
CM Life Sciences intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
|IPO Date |
Sep 2, 2020
Eli Decatur Casdin
|Stock Exchange |
|Ticker Symbol |